eLaws | eCases | United States Code | Federal Courts |
Home » Rulemaking » Rudolph Joseph Maier, MD - Comment

Rudolph Joseph Maier, MD - Comment

Document ID: FDA-2011-N-0802-0002
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: November 29 2011, at 12:00 AM Eastern Standard Time
Date Posted: February 28 2012, at 12:00 AM Eastern Standard Time
Comment Start Date: November 17 2011, at 12:00 AM Eastern Standard Time
Comment Due Date: June 12 2012, at 11:59 PM Eastern Standard Time
Tracking Number: 80f758d7
View Document:  View as format xml

View Comment

The ready availability of naloxone to reverse intended or unintended overdose of opioids is to be encouraged. It is likely to save many lives and isn't likely to present a risk to the public. I urge it's acceptance by the FDA

Related Comments

    View All
Total: 37
Rudolph Joseph Maier, MD - Comment
Public Submission    Posted: 02/28/2012     ID: FDA-2011-N-0802-0002

Jun 12,2012 11:59 PM ET
Pain Treatment Topics (Pain-Topics.org) - Comment
Public Submission    Posted: 04/12/2012     ID: FDA-2011-N-0802-0003

Jun 12,2012 11:59 PM ET
mark eisenberg - Comment
Public Submission    Posted: 04/12/2012     ID: FDA-2011-N-0802-0005

Jun 12,2012 11:59 PM ET
Mary Kay Borgstrom - Comment
Public Submission    Posted: 04/12/2012     ID: FDA-2011-N-0802-0006

Jun 12,2012 11:59 PM ET
Jeffrey Joseph Cece - Comment
Public Submission    Posted: 04/12/2012     ID: FDA-2011-N-0802-0007

Jun 12,2012 11:59 PM ET